General MedicationsORALGeneric

PHOSLO GELCAPS

CALCIUM ACETATE

Standard Dose

667MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Max Dose

Refer to approved labeling

Primary Use

Review priority: STANDARD Marketing status: Discontinued

Summary

Approval overview PHOSLO GELCAPS is listed in Drugs@FDA under application 021160 (NDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient CALCIUM ACETATE Form and strength CAPSULE;ORAL - 667MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor FRESENIUS MEDCL CARE Submission history Latest submission status date: 2016-06-22 00:00:00.

Structured Monograph

Clinical summary

Approval overview PHOSLO GELCAPS is listed in Drugs@FDA under application 021160 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient CALCIUM ACETATE Form and strength CAPSULE;ORAL - 667MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor FRESENIUS MEDCL CARE Submission history Latest submission status date: 2016-06-22 00:00:00. Submission type: SUPPL.

Monitoring

• Marketing status: Discontinued
• Review priority: STANDARD

Interaction Notes

No interaction notes stored yet.